Insider · CIK 0001751804
Laura Hamill
director
Files at JAZZ (Jazz Pharmaceuticals plc), YMAB (Y-mAbs Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | JAZZ Jazz Pharmaceuticals plc | FTax withholding Ordinary Shares | -14 | $244.06 | $3,417 | 8,524 | 40 d ago |
| Aug 31, 2026 | JAZZ Jazz Pharmaceuticals plc | FTax withholding Ordinary Shares | -1,692 | $241.39 | $408k | 6,832 | 40 d ago |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | UTender of shares Common Stock | -5,825 | $8.60 | $50k | 0 | Sep 19, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Common Stock | -25,080 | - | - | 0 | Sep 19, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -27,000 | - | - | 0 | Sep 19, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -11,000 | - | - | 0 | Sep 19, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -16,000 | - | - | 0 | Sep 19, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -13,950 | - | - | 0 | Sep 19, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -14,545 | - | - | 0 | Sep 19, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -33,450 | - | - | 0 | Sep 19, 2025 |
| Aug 7, 2025 | JAZZ Jazz Pharmaceuticals plc | AGrant or award Ordinary Shares | +3,507 | $0.00 | $0 | 8,738 | Aug 11, 2025 |
| Aug 8, 2025 | JAZZ Jazz Pharmaceuticals plc | FTax withholding Ordinary Shares | -1,805 | $111.25 | $201k | 6,933 | Aug 11, 2025 |
| Jun 30, 2025 | YMAB Y-mAbs Therapeutics, Inc. | AGrant or award Common Stock | +25,080 | $0.00 | $0 | 30,905 | Jul 2, 2025 |
| Jun 30, 2025 | YMAB Y-mAbs Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +33,450 | $0.00 | $0 | 33,450 | Jul 2, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.